AAAAAA

   
Results: 1-17 |
Results: 17
Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents
Authors: Griebel, G Perrault, G Soubrie, P
Citation: G. Griebel et al., Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents, PSYCHOPHAR, 158(3), 2001, pp. 241-251
SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats
Authors: Deroche-Gamonet, V Le Moal, M Piazza, PV Soubrie, P
Citation: V. Deroche-gamonet et al., SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats, PSYCHOPHAR, 157(3), 2001, pp. 254-259
Expression of tachykinin NK2 receptor mRNA in human brain
Authors: Bensaid, M Faucheux, BA Hirsch, E Agid, Y Soubrie, P Oury-Donat, F
Citation: M. Bensaid et al., Expression of tachykinin NK2 receptor mRNA in human brain, NEUROSCI L, 303(1), 2001, pp. 25-28
Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function
Authors: Steinberg, R Alonso, R Griebel, G Bert, L Jung, M Oury-Donat, F Poncelet, M Gueudet, C Desvignes, C Le Fur, G Soubrie, P
Citation: R. Steinberg et al., Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function, J PHARM EXP, 299(2), 2001, pp. 449-458
Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist
Authors: Brun, P Leonetti, M Sotty, F Steinberg, R Soubrie, P Renaud, B Suaud-Chagny, MF
Citation: P. Brun et al., Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist, J NEUROCHEM, 77(6), 2001, pp. 1542-1552
Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons
Authors: Michaud, JC Gueudet, C Soubrie, P
Citation: Jc. Michaud et al., Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons, NEUROREPORT, 11(7), 2000, pp. 1437-1441
Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine lnthe rat prefrontal cortex and nucleus accumbens
Authors: Sotty, F Brun, P Leonetti, M Steinberg, R Soubrie, P Renaud, B Suaud-Chagny, MF
Citation: F. Sotty et al., Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine lnthe rat prefrontal cortex and nucleus accumbens, NEUROSCIENC, 98(3), 2000, pp. 485-492
Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons
Authors: Auclair, N Otani, S Soubrie, P Crepel, F
Citation: N. Auclair et al., Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons, J NEUROPHYS, 83(6), 2000, pp. 3287-3293
Control by GABA and tachykinins of the evoked release of acetylcholine in striatal compartments under different modalities of NMDA receptor stimulation
Authors: Blanchet, F Gauchy, C Perez, S Soubrie, P Glowinski, J Kemel, ML
Citation: F. Blanchet et al., Control by GABA and tachykinins of the evoked release of acetylcholine in striatal compartments under different modalities of NMDA receptor stimulation, BRAIN RES, 853(1), 2000, pp. 142-150
Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils
Authors: Poncelet, M Barnouin, MC Breliere, JC Le Fur, G Soubrie, P
Citation: M. Poncelet et al., Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils, PSYCHOPHAR, 144(2), 1999, pp. 144-150
Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain
Authors: Alonso, R Gnanadicom, H Frechin, N Fournier, M Le Fur, G Soubrie, P
Citation: R. Alonso et al., Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain, EUR J NEURO, 11(3), 1999, pp. 967-974
Blockade of neurokinin(3) receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs
Authors: Gueudet, C Santucci, V Soubrie, P Le Fur, G
Citation: C. Gueudet et al., Blockade of neurokinin(3) receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs, SYNAPSE, 33(1), 1999, pp. 71-79
Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D-2 function
Authors: Alonso, R Voutsinos, B Fournier, M Labie, C Steinberg, R Souilhac, J Le Fur, G Soubrie, P
Citation: R. Alonso et al., Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D-2 function, NEUROSCIENC, 91(2), 1999, pp. 607-620
SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I: In vitro studies
Authors: Bignon, E Bachy, A Boigegrain, R Brodin, R Cottineau, M Gully, D Herbert, JM Keane, P Labie, C Molimard, JC Olliero, D Oury-Donat, F Petereau, C Prabonnaud, V Rockstroh, MP Schaeffer, P Servant, O Thurneyssen, O Soubrie, P Pascal, M Maffrand, JP Le Fur, G
Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I: In vitro studies, J PHARM EXP, 289(2), 1999, pp. 742-751
SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II: In vivo pharmacological characterization
Authors: Bignon, E Alonso, R Arnone, M Boigegrain, R Brodin, R Gueudet, C Heaulme, M Keane, P Landi, M Molimard, JC Olliero, D Poncelet, M Seban, E Simiand, J Soubrie, P Pascal, M Maffrand, JP Le Fur, G
Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II: In vivo pharmacological characterization, J PHARM EXP, 289(2), 1999, pp. 752-761
Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex
Authors: Labie, C Lafon, C Marmouget, C Saubusse, P Fournier, J Keane, PE Le Fur, G Soubrie, P
Citation: C. Labie et al., Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex, BR J PHARM, 127(1), 1999, pp. 139-144
The non-peptide neuroprotective agent SR 57746A interacts with neurotrophin-3 to induce differentiation in the PC12 cell-line
Authors: Fournier, J Boutot, G Keane, PE Maffrand, JP Le Fur, G Soubrie, P
Citation: J. Fournier et al., The non-peptide neuroprotective agent SR 57746A interacts with neurotrophin-3 to induce differentiation in the PC12 cell-line, J PHARM PHA, 50(3), 1998, pp. 323-327
Risultati: 1-17 |